Skip to main content

Want a detailed portfolio tracker?

Performance analysis of RenovoRx (RNXT)

Annual Return

Over the past 3 years, RNXT has had an average annual return of -24.91%, underperforming the benchmark SPY, which returned +19.63% annual.

Since Aug 26, 2021, RNXT has had an average annual return of -35.00%, underperforming the benchmark SPY, which returned +12.66% annual.

202620252024202320222021
+4.49%-34.89%-43.66%-2.56%-51.45%-33.33%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026+23.85%-15.14%+14.39%-15.82%+7%+7.74%-10.44%+4.49%
2025+5.40%-26.48%-0.94%-3.08%+45.84%-6.07%-5.69%-22.60%+32.30%-12.58%-17.33%-8.47%-34.89%
2024-34.50%+14.67%-22.08%-9.70%-4.14%-2.63%+6.23%-15.00%+3.91%-5.82%+27.20%+1.60%-43.66%
2023+11.92%+76.79%-25.06%-10.19%-40.57%+21.51%-12.40%-18.19%-17.88%-14.30%-43.82%+257.60%-2.56%
2022-31.41%+1.20%-12.79%-43.01%+17.39%+1%-1.80%+8.03%-3.84%-13.37%+11.45%+20.51%-51.45%
2021+37.60%-39.53%-14.24%+36.68%-31.63%-33.33%

Drawdown analysis of RenovoRx (RNXT)

The maximum drawdown for the RNXT was -96.26%, occurring on Nov 17, 2023. This drawdown has not yet recovered.

The current RNXT drawdown is -94.52%.

Since Aug 26, 2021 RNXT has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 1 time
DepthStartTo BottomBottomTo RecoverEndTotal
-96.26%Aug 30, 2021559Nov 17, 2023OngoingOngoingOngoing